ArticleInternational journal of hematology2026
Improved post-transplant outcomes following inotuzumab ozogamicin-based salvage therapy in relapsed/refractory B-ALL: a real-world retrospective study.
Ryo Koizumi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.